View in EDS HTML Full Text PDF Full Text

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Saved in:
Bibliographic Details
Title: Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.
Authors: Tursi, Antonio1,2 (AUTHOR) antotursi@tiscali.it, Mocci, Giammarco3 (AUTHOR), Costa, Francesco4 (AUTHOR), Ceccarelli, Linda4 (AUTHOR), Savarino, Edoardo5 (AUTHOR), De Barba, Caterina5 (AUTHOR), Mucherino, Caterina6 (AUTHOR), D'Antonio, Elvira6 (AUTHOR), Montesano, Laura6 (AUTHOR), Marzo, Manuela7 (AUTHOR), Scaldaferri, Franco8,9 (AUTHOR), Napolitano, Daniele8 (AUTHOR), Pugliese, Daniela8,9 (AUTHOR), Gravina, Antonietta Gerarda10 (AUTHOR), Pellegrino, Raffaele10 (AUTHOR), Spagnuolo, Rocco11 (AUTHOR), Luzza, Francesco11 (AUTHOR), Cuomo, Antonio12 (AUTHOR), Donnarumma, Laura12 (AUTHOR), Maconi, Giovanni13 (AUTHOR)
Source: Intestinal Research. Apr2026, Vol. 24 Issue 2, p341-351. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15989100
DOI:10.5217/ir.2025.00067